Trial intelligence / Profile preview

MenSCs Transplantation in Liver Cirrhosis

NCT01483248Phase 2Unknown

Sponsor
S-Evans Biosciences
Start
Oct 2010
Primary completion
Oct 2013
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of menstrual blood-derived mesenchymal stem cells in Liver cirrhosis (LC), sponsored by S-Evans Biosciences. Status: unknown.

02

Drugs

menstrual blood-derived mesenchymal stem cells
03

Conditions

Liver cirrhosis (LC)

Beyond the preview

Go deeper on NCT01483248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01483248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call